Stem cell therapies, regenerative medicine, tissue engineering, and cellular reprogramming
188 artigos
A Phase 1/2 trial tests four rounds of intrathecal MSC injections in ALS patients, targeting both safety and disease progression.
New research in Nature Aging suggests tissue mechanical softness is a critical factor enabling cellular regeneration, with major implications for aging biology.
Vá mais fundo em como os exossomos são construídos, o que eles carregam e como sua carga molecular reprograma as células receptoras — com implicações para regeneração, envelhecimento e terapias emergentes.
Harvard's CellCartographer uses machine learning to identify optimal transcription factor combinations for rapid, high-efficiency cell reprogramming.
Kyoto researchers created jawbone-like organoids from human iPSCs, recapitulating mandibular development and modeling fragile bone disease.
Chinese researchers decode how chemical cocktails alone can convert adult human cells into pluripotent stem cells, bypassing gene editing.
A review of iPSC-based regenerative medicine charts the path from Parkinson's disease models to real-world cell replacement therapies.
Descubra os exossomos — as "mensagens de texto" microscópicas que suas células enviam para coordenar a cura, o envelhecimento e o reparo em todo o seu organismo.
Astellas reports encouraging early-stage results for a stem cell-derived treatment targeting age-related eye disease, though data remains limited.
A comprehensive review maps how mesenchymal stem cells and their exosomes combat Alzheimer's, atherosclerosis, osteoporosis, and ovarian failure.
A novel photoactivatable drug system uses NK immune cells to eliminate aging joint cells, reducing osteoarthritis progression in mice.
Combining nanoparticles with mesenchymal stem cells could finally overcome the poor survival and differentiation that limits cartilage regeneration.
